Viewing StudyNCT00389285



Ignite Creation Date: 2024-05-05 @ 5:04 PM
Last Modification Date: 2024-10-26 @ 9:28 AM
Study NCT ID: NCT00389285
Status: COMPLETED
Last Update Posted: 2009-05-27
First Post: 2006-10-16

Brief Title: Study of Recombinant Interleukin 21 in Combination With Sorafenib for Metastatic Renal Cell Carcinoma
Sponsor: ZymoGenetics
Organization: ZymoGenetics

Conditions & Keywords Data

Conditions:
Name
Carcinoma Renal Cell
Keywords:
Name View
Immunotherapy View
Carcinoma renal cell View
interleukin-21 View
sorafenib View